References
- Group ACTS phase I-II. The amyotrophic lateral sclerosis functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996;53:141–7.
- Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS func- tional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13–21.
- Group ACTS. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurol. 1996;46:1244–9.
- Cedarbaum JM, Stambler N. Performance of the ALS Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci. 1997; 152(Suppl 1): 1–9.
- Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci. 2001;191:75–8.
- Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr., Johnson H, Qureshi M, et al. A randomized, placebo- controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology. 2003;61:456–64.
- Miller RG, Moore DH II, Gelinas DF, Dronsky V, Mendoza M, Barohn RJ, et al. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology. 2001;56:843–8.
- A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology. 1999;52:1427–33.
- Kasarskis EJ, Dominick K, Oddone EZ. The national registry of veterans with amyotrophic lateral sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) 500a Amyotroph Lateral Scler Other Motor Neuron Disord. 2004, Suppl 1: 129–32.
- Florence J, Moore D, Mendoza M, Mass J, Renna R, Malinowski L, et al. Validation of telephonic administration of the ALSFRS-R. Neurology. 2004; 62(Suppl 5): A134.
- Portet F, Cadilhac C, Touchon J, Camu W. Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2(1): 23–9.
- Olney RK, Murphy J, Forshew DA, Garwood E, Miller B, Langmore S, et al. The effects of executive and behavioral dysfunction on the course of amyotrophic lateral sclerosis. Neurology. 2004; 62(Suppl 5): A280.
- Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124(Suppl): 96–107.